APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propofol Injection for Operation General Anesthesia

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Propofol Injection for Operation General Anesthesia Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchPropofol Injection for Operation General Anesthesia Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Injection for Operation General Anesthesia Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Propofol Injection for Operation General Anesthesia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Injection for Operation General Anesthesia Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Injection for Operation General Anesthesia Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Propofol Injection for Operation General Anesthesia market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Propofol Injection for Operation General Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol Injection for Operation General Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol Injection for Operation General Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Propofol Injection for Operation General Anesthesia market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Propofol Injection for Operation General Anesthesia market include Yichang Humanwell, Xi'an Libang, Nhwa, Hengrui, China National Medicines Guorui Pharmaceutical Co.,Ltd., Fresenius-Kabi, Baxter Healthcare, AbbVie and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Propofol Injection for Operation General Anesthesia market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol Injection for Operation General Anesthesia and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol Injection for Operation General Anesthesia sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol Injection for Operation General Anesthesia market size, projected growth trends, production technologies, key applications, and end-use industries.

Propofol Injection for Operation General Anesthesia Segment by Company

Yichang Humanwell

Xi'an Libang

Nhwa

Hengrui

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Fresenius-Kabi

Baxter Healthcare

AbbVie

AstraZeneca

Piramal

Maruishi

Hikma Pharmaceuticals

B.Braun

Aspen Pharma

Propofol Injection for Operation General Anesthesia Segment by Type

10ml

20ml

50ml

Others

Propofol Injection for Operation General Anesthesia Segment by Application

Hopitals

Clinics

Others

Propofol Injection for Operation General Anesthesia Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Propofol Injection for Operation General Anesthesia status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Propofol Injection for Operation General Anesthesia market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Propofol Injection for Operation General Anesthesia significant trends, drivers, influence factors in global and regions.

6. To analyze Propofol Injection for Operation General Anesthesia competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Injection for Operation General Anesthesia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Injection for Operation General Anesthesia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Injection for Operation General Anesthesia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Propofol Injection for Operation General Anesthesia market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Propofol Injection for Operation General Anesthesia industry.

Chapter 3: Detailed analysis of Propofol Injection for Operation General Anesthesia manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Propofol Injection for Operation General Anesthesia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Propofol Injection for Operation General Anesthesia in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Propofol Injection for Operation General Anesthesia Industry Trends Table 2. Propofol Injection for Operation General Anesthesia Industry Drivers Table 3. Propofol Injection for Operation General Anesthesia Industry Opportunities and Challenges Table 4. Propofol Injection for Operation General Anesthesia Industry Restraints Table 5. Global Propofol Injection for Operation General Anesthesia Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Propofol Injection for Operation General Anesthesia Revenue Share by Company (2021-2026) Table 7. Global Propofol Injection for Operation General Anesthesia Sales Volume by Company (k units) & (2021-2026) Table 8. Global Propofol Injection for Operation General Anesthesia Sales Volume Share by Company (2021-2026) Table 9. Global Propofol Injection for Operation General Anesthesia Average Price (US$/unit) of Company (2021-2026) Table 10. Global Propofol Injection for Operation General Anesthesia Company Ranking, (2024-2026) & (USD Million) Table 11. Global Propofol Injection for Operation General Anesthesia Key Company Manufacturing Base & Headquarters Table 12. Global Propofol Injection for Operation General Anesthesia Company, Product Type & Application Table 13. Global Propofol Injection for Operation General Anesthesia Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Propofol Injection for Operation General Anesthesia by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10ml Table 18. Significant Companies of 20ml Table 19. Significant Companies of 50ml Table 20. Significant Companies of Others Table 21. Global Propofol Injection for Operation General Anesthesia Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Propofol Injection for Operation General Anesthesia Sales Volume by Type (2021-2026) & (k units) Table 23. Global Propofol Injection for Operation General Anesthesia Sales Volume by Type (2027-2032) & (k units) Table 24. Global Propofol Injection for Operation General Anesthesia Sales Volume Share by Type (2021-2026) Table 25. Global Propofol Injection for Operation General Anesthesia Sales Volume Share by Type (2027-2032) Table 26. Global Propofol Injection for Operation General Anesthesia Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Propofol Injection for Operation General Anesthesia Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Propofol Injection for Operation General Anesthesia Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Propofol Injection for Operation General Anesthesia Sales Value Share by Type (2021-2026) Table 30. Global Propofol Injection for Operation General Anesthesia Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hopitals Table 32. Significant Companies of Clinics Table 33. Significant Companies of Others Table 34. Global Propofol Injection for Operation General Anesthesia Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Propofol Injection for Operation General Anesthesia Sales Volume by Application (2021-2026) & (k units) Table 36. Global Propofol Injection for Operation General Anesthesia Sales Volume by Application (2027-2032) & (k units) Table 37. Global Propofol Injection for Operation General Anesthesia Sales Volume Share by Application (2021-2026) Table 38. Global Propofol Injection for Operation General Anesthesia Sales Volume Share by Application (2027-2032) Table 39. Global Propofol Injection for Operation General Anesthesia Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Propofol Injection for Operation General Anesthesia Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Propofol Injection for Operation General Anesthesia Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Propofol Injection for Operation General Anesthesia Sales Value Share by Application (2021-2026) Table 43. Global Propofol Injection for Operation General Anesthesia Sales Value Share by Application (2027-2032) Table 44. Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Propofol Injection for Operation General Anesthesia Sales by Region (2021-2026) & (k units) Table 46. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2021-2026) Table 47. Global Propofol Injection for Operation General Anesthesia Sales by Region (2027-2032) & (k units) Table 48. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region (2027-2032) Table 49. Global Propofol Injection for Operation General Anesthesia Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Propofol Injection for Operation General Anesthesia Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Propofol Injection for Operation General Anesthesia Sales Value Share by Region (2021-2026) Table 52. Global Propofol Injection for Operation General Anesthesia Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Propofol Injection for Operation General Anesthesia Sales Value Share by Region (2027-2032) Table 54. Global Propofol Injection for Operation General Anesthesia Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Propofol Injection for Operation General Anesthesia Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Propofol Injection for Operation General Anesthesia Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Propofol Injection for Operation General Anesthesia Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026) & (k units) Table 59. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2021-2026) Table 60. Global Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032) & (k units) Table 61. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Country (2027-2032) Table 62. Global Propofol Injection for Operation General Anesthesia Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Propofol Injection for Operation General Anesthesia Sales Value Market Share by Country (2021-2026) Table 64. Global Propofol Injection for Operation General Anesthesia Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Propofol Injection for Operation General Anesthesia Sales Value Market Share by Country (2027-2032) Table 66. Yichang Humanwell Company Information Table 67. Yichang Humanwell Business Overview Table 68. Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Yichang Humanwell Propofol Injection for Operation General Anesthesia Product Portfolio Table 70. Yichang Humanwell Recent Development Table 71. Xi'an Libang Company Information Table 72. Xi'an Libang Business Overview Table 73. Xi'an Libang Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Xi'an Libang Propofol Injection for Operation General Anesthesia Product Portfolio Table 75. Xi'an Libang Recent Development Table 76. Nhwa Company Information Table 77. Nhwa Business Overview Table 78. Nhwa Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Nhwa Propofol Injection for Operation General Anesthesia Product Portfolio Table 80. Nhwa Recent Development Table 81. Hengrui Company Information Table 82. Hengrui Business Overview Table 83. Hengrui Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Hengrui Propofol Injection for Operation General Anesthesia Product Portfolio Table 85. Hengrui Recent Development Table 86. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information Table 87. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview Table 88. China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product Portfolio Table 90. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Development Table 91. Fresenius-Kabi Company Information Table 92. Fresenius-Kabi Business Overview Table 93. Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product Portfolio Table 95. Fresenius-Kabi Recent Development Table 96. Baxter Healthcare Company Information Table 97. Baxter Healthcare Business Overview Table 98. Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Baxter Healthcare Propofol Injection for Operation General Anesthesia Product Portfolio Table 100. Baxter Healthcare Recent Development Table 101. AbbVie Company Information Table 102. AbbVie Business Overview Table 103. AbbVie Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. AbbVie Propofol Injection for Operation General Anesthesia Product Portfolio Table 105. AbbVie Recent Development Table 106. AstraZeneca Company Information Table 107. AstraZeneca Business Overview Table 108. AstraZeneca Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. AstraZeneca Propofol Injection for Operation General Anesthesia Product Portfolio Table 110. AstraZeneca Recent Development Table 111. Piramal Company Information Table 112. Piramal Business Overview Table 113. Piramal Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Piramal Propofol Injection for Operation General Anesthesia Product Portfolio Table 115. Piramal Recent Development Table 116. Maruishi Company Information Table 117. Maruishi Business Overview Table 118. Maruishi Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Maruishi Propofol Injection for Operation General Anesthesia Product Portfolio Table 120. Maruishi Recent Development Table 121. Hikma Pharmaceuticals Company Information Table 122. Hikma Pharmaceuticals Business Overview Table 123. Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product Portfolio Table 125. Hikma Pharmaceuticals Recent Development Table 126. B.Braun Company Information Table 127. B.Braun Business Overview Table 128. B.Braun Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. B.Braun Propofol Injection for Operation General Anesthesia Product Portfolio Table 130. B.Braun Recent Development Table 131. Aspen Pharma Company Information Table 132. Aspen Pharma Business Overview Table 133. Aspen Pharma Propofol Injection for Operation General Anesthesia Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Aspen Pharma Propofol Injection for Operation General Anesthesia Product Portfolio Table 135. Aspen Pharma Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Propofol Injection for Operation General Anesthesia Distributors List Table 139. Propofol Injection for Operation General Anesthesia Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Propofol Injection for Operation General Anesthesia Product Image Figure 2. Global Propofol Injection for Operation General Anesthesia Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Injection for Operation General Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 4. Global Propofol Injection for Operation General Anesthesia Sales (2021-2032) & (k units) Figure 5. Global Propofol Injection for Operation General Anesthesia Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Propofol Injection for Operation General Anesthesia Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10ml Image Figure 10. 20ml Image Figure 11. 50ml Image Figure 12. Others Image Figure 13. Global Propofol Injection for Operation General Anesthesia Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Propofol Injection for Operation General Anesthesia Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Propofol Injection for Operation General Anesthesia Sales Volume Share by Type (2021-2032) Figure 16. Global Propofol Injection for Operation General Anesthesia Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Propofol Injection for Operation General Anesthesia Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Propofol Injection for Operation General Anesthesia Sales Value Share by Type (2021-2032) Figure 19. Hopitals Image Figure 20. Clinics Image Figure 21. Others Image Figure 22. Global Propofol Injection for Operation General Anesthesia Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Propofol Injection for Operation General Anesthesia Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Propofol Injection for Operation General Anesthesia Sales Volume Share by Application (2021-2032) Figure 25. Global Propofol Injection for Operation General Anesthesia Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Propofol Injection for Operation General Anesthesia Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Propofol Injection for Operation General Anesthesia Sales Value Share by Application (2021-2032) Figure 28. Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Propofol Injection for Operation General Anesthesia Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Propofol Injection for Operation General Anesthesia Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Propofol Injection for Operation General Anesthesia Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Propofol Injection for Operation General Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 33. North America Propofol Injection for Operation General Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Propofol Injection for Operation General Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Propofol Injection for Operation General Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Propofol Injection for Operation General Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Propofol Injection for Operation General Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Propofol Injection for Operation General Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 39. South America Propofol Injection for Operation General Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Propofol Injection for Operation General Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Propofol Injection for Operation General Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Propofol Injection for Operation General Anesthesia Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Propofol Injection for Operation General Anesthesia Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml
  • 20ml
  • 50ml
  • Others
Applications
  • Hopitals
  • Clinics
  • Others
Companies covered
  • Yichang Humanwell
  • Xi'an Libang
  • Nhwa
  • Hengrui
  • China National Medicines Guorui Pharmaceutical Co.,Ltd.
  • Fresenius-Kabi
  • Baxter Healthcare
  • AbbVie
  • AstraZeneca
  • Piramal
  • Maruishi
  • Hikma Pharmaceuticals
  • B.Braun
  • Aspen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Propofol Injection for Operation General Anesthesia Sales Value (2021-2032)
  4. 1.2.2 Global Propofol Injection for Operation General Anesthesia Sales Volume (2021-2032)
  5. 1.2.3 Global Propofol Injection for Operation General Anesthesia Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Propofol Injection for Operation General Anesthesia Market Dynamics
  1. 2.1 Propofol Injection for Operation General Anesthesia Industry Trends
  2. 2.2 Propofol Injection for Operation General Anesthesia Industry Drivers
  3. 2.3 Propofol Injection for Operation General Anesthesia Industry Opportunities and Challenges
  4. 2.4 Propofol Injection for Operation General Anesthesia Industry Restraints
3 Propofol Injection for Operation General Anesthesia Market by Company
  1. 3.1 Global Propofol Injection for Operation General Anesthesia Company Revenue Ranking in 2025
  2. 3.2 Global Propofol Injection for Operation General Anesthesia Revenue by Company (2021-2026)
  3. 3.3 Global Propofol Injection for Operation General Anesthesia Sales Volume by Company (2021-2026)
  4. 3.4 Global Propofol Injection for Operation General Anesthesia Average Price by Company (2021-2026)
  5. 3.5 Global Propofol Injection for Operation General Anesthesia Company Ranking (2024-2026)
  6. 3.6 Global Propofol Injection for Operation General Anesthesia Company Manufacturing Base and Headquarters
  7. 3.7 Global Propofol Injection for Operation General Anesthesia Company Product Type and Application
  8. 3.8 Global Propofol Injection for Operation General Anesthesia Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Propofol Injection for Operation General Anesthesia Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Propofol Injection for Operation General Anesthesia Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Propofol Injection for Operation General Anesthesia Market by Type
  1. 4.1 Propofol Injection for Operation General Anesthesia Type Introduction
  2. 4.1.1 10ml
  3. 4.1.2 20ml
  4. 4.1.3 50ml
  5. 4.1.4 Others
  6. 4.2 Global Propofol Injection for Operation General Anesthesia Sales Volume by Type
  7. 4.2.1 Global Propofol Injection for Operation General Anesthesia Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Propofol Injection for Operation General Anesthesia Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Propofol Injection for Operation General Anesthesia Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Propofol Injection for Operation General Anesthesia Sales Value by Type
  11. 4.3.1 Global Propofol Injection for Operation General Anesthesia Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Propofol Injection for Operation General Anesthesia Sales Value by Type (2021-2032)
  13. 4.3.3 Global Propofol Injection for Operation General Anesthesia Sales Value Share by Type (2021-2032)
5 Propofol Injection for Operation General Anesthesia Market by Application
  1. 5.1 Propofol Injection for Operation General Anesthesia Application Introduction
  2. 5.1.1 Hopitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Propofol Injection for Operation General Anesthesia Sales Volume by Application
  6. 5.2.1 Global Propofol Injection for Operation General Anesthesia Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol Injection for Operation General Anesthesia Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Propofol Injection for Operation General Anesthesia Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Propofol Injection for Operation General Anesthesia Sales Value by Application
  10. 5.3.1 Global Propofol Injection for Operation General Anesthesia Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Propofol Injection for Operation General Anesthesia Sales Value by Application (2021-2032)
  12. 5.3.3 Global Propofol Injection for Operation General Anesthesia Sales Value Share by Application (2021-2032)
6 Propofol Injection for Operation General Anesthesia Regional Sales and Value Analysis
  1. 6.1 Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol Injection for Operation General Anesthesia Sales by Region (2021-2032)
  3. 6.2.1 Global Propofol Injection for Operation General Anesthesia Sales by Region: 2021-2026
  4. 6.2.2 Global Propofol Injection for Operation General Anesthesia Sales by Region (2027-2032)
  5. 6.3 Global Propofol Injection for Operation General Anesthesia Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Propofol Injection for Operation General Anesthesia Sales Value by Region (2021-2032)
  7. 6.4.1 Global Propofol Injection for Operation General Anesthesia Sales Value by Region: 2021-2026
  8. 6.4.2 Global Propofol Injection for Operation General Anesthesia Sales Value by Region (2027-2032)
  9. 6.5 Global Propofol Injection for Operation General Anesthesia Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Propofol Injection for Operation General Anesthesia Sales Value (2021-2032)
  12. 6.6.2 North America Propofol Injection for Operation General Anesthesia Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Propofol Injection for Operation General Anesthesia Sales Value (2021-2032)
  15. 6.7.2 Europe Propofol Injection for Operation General Anesthesia Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Propofol Injection for Operation General Anesthesia Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Propofol Injection for Operation General Anesthesia Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Propofol Injection for Operation General Anesthesia Sales Value (2021-2032)
  21. 6.9.2 South America Propofol Injection for Operation General Anesthesia Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Propofol Injection for Operation General Anesthesia Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Propofol Injection for Operation General Anesthesia Sales Value Share by Country, 2025 VS 2032
7 Propofol Injection for Operation General Anesthesia Country-level Sales and Value Analysis
  1. 7.1 Global Propofol Injection for Operation General Anesthesia Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Propofol Injection for Operation General Anesthesia Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Propofol Injection for Operation General Anesthesia Sales by Country (2021-2032)
  4. 7.3.1 Global Propofol Injection for Operation General Anesthesia Sales by Country (2021-2026)
  5. 7.3.2 Global Propofol Injection for Operation General Anesthesia Sales by Country (2027-2032)
  6. 7.4 Global Propofol Injection for Operation General Anesthesia Sales Value by Country (2021-2032)
  7. 7.4.1 Global Propofol Injection for Operation General Anesthesia Sales Value by Country (2021-2026)
  8. 7.4.2 Global Propofol Injection for Operation General Anesthesia Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Propofol Injection for Operation General Anesthesia Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Propofol Injection for Operation General Anesthesia Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Propofol Injection for Operation General Anesthesia Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yichang Humanwell
  2. 8.1.1 Yichang Humanwell Company Information
  3. 8.1.2 Yichang Humanwell Business Overview
  4. 8.1.3 Yichang Humanwell Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yichang Humanwell Propofol Injection for Operation General Anesthesia Product Portfolio
  6. 8.1.5 Yichang Humanwell Recent Developments
  7. 8.2 Xi'an Libang
  8. 8.2.1 Xi'an Libang Company Information
  9. 8.2.2 Xi'an Libang Business Overview
  10. 8.2.3 Xi'an Libang Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Libang Propofol Injection for Operation General Anesthesia Product Portfolio
  12. 8.2.5 Xi'an Libang Recent Developments
  13. 8.3 Nhwa
  14. 8.3.1 Nhwa Company Information
  15. 8.3.2 Nhwa Business Overview
  16. 8.3.3 Nhwa Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Nhwa Propofol Injection for Operation General Anesthesia Product Portfolio
  18. 8.3.5 Nhwa Recent Developments
  19. 8.4 Hengrui
  20. 8.4.1 Hengrui Company Information
  21. 8.4.2 Hengrui Business Overview
  22. 8.4.3 Hengrui Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hengrui Propofol Injection for Operation General Anesthesia Product Portfolio
  24. 8.4.5 Hengrui Recent Developments
  25. 8.5 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  26. 8.5.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
  27. 8.5.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  28. 8.5.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Propofol Injection for Operation General Anesthesia Product Portfolio
  30. 8.5.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
  31. 8.6 Fresenius-Kabi
  32. 8.6.1 Fresenius-Kabi Company Information
  33. 8.6.2 Fresenius-Kabi Business Overview
  34. 8.6.3 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius-Kabi Propofol Injection for Operation General Anesthesia Product Portfolio
  36. 8.6.5 Fresenius-Kabi Recent Developments
  37. 8.7 Baxter Healthcare
  38. 8.7.1 Baxter Healthcare Company Information
  39. 8.7.2 Baxter Healthcare Business Overview
  40. 8.7.3 Baxter Healthcare Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Baxter Healthcare Propofol Injection for Operation General Anesthesia Product Portfolio
  42. 8.7.5 Baxter Healthcare Recent Developments
  43. 8.8 AbbVie
  44. 8.8.1 AbbVie Company Information
  45. 8.8.2 AbbVie Business Overview
  46. 8.8.3 AbbVie Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie Propofol Injection for Operation General Anesthesia Product Portfolio
  48. 8.8.5 AbbVie Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Propofol Injection for Operation General Anesthesia Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 Piramal
  56. 8.10.1 Piramal Company Information
  57. 8.10.2 Piramal Business Overview
  58. 8.10.3 Piramal Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Piramal Propofol Injection for Operation General Anesthesia Product Portfolio
  60. 8.10.5 Piramal Recent Developments
  61. 8.11 Maruishi
  62. 8.11.1 Maruishi Company Information
  63. 8.11.2 Maruishi Business Overview
  64. 8.11.3 Maruishi Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Maruishi Propofol Injection for Operation General Anesthesia Product Portfolio
  66. 8.11.5 Maruishi Recent Developments
  67. 8.12 Hikma Pharmaceuticals
  68. 8.12.1 Hikma Pharmaceuticals Company Information
  69. 8.12.2 Hikma Pharmaceuticals Business Overview
  70. 8.12.3 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hikma Pharmaceuticals Propofol Injection for Operation General Anesthesia Product Portfolio
  72. 8.12.5 Hikma Pharmaceuticals Recent Developments
  73. 8.13 B.Braun
  74. 8.13.1 B.Braun Company Information
  75. 8.13.2 B.Braun Business Overview
  76. 8.13.3 B.Braun Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 B.Braun Propofol Injection for Operation General Anesthesia Product Portfolio
  78. 8.13.5 B.Braun Recent Developments
  79. 8.14 Aspen Pharma
  80. 8.14.1 Aspen Pharma Company Information
  81. 8.14.2 Aspen Pharma Business Overview
  82. 8.14.3 Aspen Pharma Propofol Injection for Operation General Anesthesia Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Aspen Pharma Propofol Injection for Operation General Anesthesia Product Portfolio
  84. 8.14.5 Aspen Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Propofol Injection for Operation General Anesthesia Value Chain Analysis
  2. 9.1.1 Propofol Injection for Operation General Anesthesia Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Propofol Injection for Operation General Anesthesia Sales Mode & Process
  6. 9.2 Propofol Injection for Operation General Anesthesia Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Propofol Injection for Operation General Anesthesia Distributors
  9. 9.2.3 Propofol Injection for Operation General Anesthesia Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst